Newsroom

Press Releases Events

Apr 9, 2021 Phase 2 Trial of BX004, Phage Therapy for Bacterial Infections, Advancing

Apr 7, 2021 Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit

Feb 11, 2021 Fierce Pharma - BiomX hails clinical data as first for oral phage delivery

Feb 10, 2021 IDB News Today - Phage Therapy BX002 Shows Promise in First-in-human Trial

Dec 15, 2020 Solebury Trout Talks - Jonathan Solomon, BiomX - Part of the Nametag Series

Dec 3, 2020 Cystic Fibrosis News Today - BiomX Testing Potential Therapy for CF Lung Infections

Nov 24, 2020 BioSpace: From Acne to Cancer, BiomX Infects Bad Bacteria with Modified Viruses

Oct 9, 2020 Bioconvergence – The next big thing from Israel

Oct 18, 2020 BiomX Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates

Nov 20, 2019 BiomX Presents Preclinical Results of Phage Targeting Klebsiella pneumoniae for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

Dec 12, 2020 Jefferies 2020 Virtual London Healthcare Conference

Sign up for the latest updates

Join our mailing list to receive company updates
delivered to your inbox Join the list

Reach Us

22 Einstein St., Floor 5
Ness Ziona 7414003
Israel

+972-72-3942377

36 E Industrial Rd
Branford, CT 06405
USA

+1-203-408-3915